Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
49.66B | 49.05B | 44.81B | 39.35B | 35.59B | 42.41B | Gross Profit |
13.20B | 12.73B | 10.41B | 9.89B | 8.76B | 9.81B | EBIT |
3.76B | 3.61B | 1.47B | 1.76B | 874.00M | 1.86B | EBITDA |
5.46B | 5.31B | 3.23B | 3.17B | 7.57B | 3.51B | Net Income Common Stockholders |
2.64B | 2.55B | 1.17B | 1.14B | 4.22B | 1.27B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
8.78B | 8.78B | 7.01B | 6.79B | 7.67B | 4.18B | Total Assets |
72.39B | 72.39B | 69.56B | 68.42B | 69.41B | 67.65B | Total Debt |
13.73B | 13.57B | 14.96B | 16.22B | 17.86B | 20.09B | Net Debt |
5.13B | 4.79B | 7.94B | 9.43B | 10.19B | 15.91B | Total Liabilities |
34.09B | 34.09B | 34.49B | 34.42B | 36.45B | 39.13B | Stockholders Equity |
37.62B | 37.62B | 34.46B | 33.41B | 32.41B | 27.99B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.42B | 1.59B | 1.02B | -805.00M | 855.00M | Operating Cash Flow |
0.00 | 4.17B | 2.67B | 2.07B | 2.76B | 1.90B | Investing Cash Flow |
0.00 | -580.00M | -821.00M | -917.00M | 3.30B | -280.00M | Financing Cash Flow |
0.00 | -1.88B | -1.67B | -2.13B | -2.59B | -1.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥33.59B | 10.46 | 2.89% | 1.88% | 8.88% | ||
78 Outperform | ¥28.56B | 11.62 | 6.04% | 0.19% | -3.57% | ||
75 Outperform | ¥24.57B | 14.01 | 4.65% | 1.57% | 20.22% | ||
74 Outperform | ¥162.09B | 11.99 | 2.54% | 10.09% | 33.98% | ||
73 Outperform | ¥2.43T | 36.34 | 29.51% | 0.52% | 20.34% | 52.96% | |
70 Outperform | ¥7.85B | 11.22 | 3.05% | -0.73% | 63.91% | ||
62 Neutral | $6.94B | 11.29 | 2.95% | 3.87% | 2.70% | -24.49% |